PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.: Good habits, safe predictions and a herd of sheep.

Dr. Rost provides services as a pharmaceutical marketing expert witness. For more info see: Drug Expert Witness. Dr. Peter Rost email. Copyright © 2006-2013 InSync Communication. All rights reserved. Terms of use agreement, privacy policy and the computer fraud and abuse act.


Peter Rost, M.D., is a former Pfizer Marketing Vice President providing services as a medical device and drug expert witness and pharmaceutical marketing expert. Judge Sanders: "The court agrees with defendants' view that Dr. Rost is a very adept and seasoned expert witness." He is also the author of Emergency Surgery, The Whistleblower and Killer Drug. You can reach him on rostpeter (insert symbol) Please read the terms of use agreement and privacy policy for this blog carefully.

Good habits, safe predictions and a herd of sheep.

The eminent journal Nature has developed the splendid habit of calling me when they write an article about Pfizer. This week they wrote an article with the headline, "Michigan lab axed as Pfizer cuts costs."

They ended the article about Pfizer eliminating 10,000 positions, saying, "And Peter Rost, a former vice-president of marketing and strident critic of Pfizer’s current management — now in litigation with the company over the circumstances of his departure in 2005 — predicts that there is worse to come. “This is just the beginning,” he says. “It is not the bottom. Two years from now, Pfizer will make another announcement, and cut another $2 billion. Just watch.”

I've repeatedly told the press that when Pfizer starts cutting the others will follow.

And so, yesterday, AstraZeneca, which reported an increase of 17 percent in fourth-quarter net profits, announced plans that they will eliminate 3000 jobs over the next three years.

These companies are pretty much like a herd of sheep. They all eagerly watch what Pfizer will do and then they do the same thing.


Anonymous ORSunshine said...

It seems that Q4 reports actually had bad news for quite a few companies (not limited to pharmas). But really, do you think everyone follows Pfizer's lead? Or is big business in the US just simply too beholden to stockholders and so completely risk-averse that their answer to not meeting their revenue targets is always cutting down and "trimming" their budget? It seems pretty unoriginal to me.


Post a Comment

Links to this post:

Create a Link

<< Home